Showing results (2351-2360 of 3,448) with videos related to

Sort By:
Pageof 345
Urology|July 18, 2006
Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomyShomik Sengupta, John C Cheville, Christine M Lohse, et al.
Endocrinology, Diabetes & Metabolism|November 20, 2021
GAD65 autoantibodies and glucose tolerance in offspring born to women with and without type 1 diabetes (The EPICOM study)Sine Knorr, Magnus C Lydolph, Birgitte Bytoft, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 21, 2022
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapyFabrice Viol, Bence Sipos, Martina Fahl, et al.
Science (New York, N.Y.)|February 27, 2010
Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentationViacheslav O Nikolaev, Alexey Moshkov, Alexander R Lyon, et al.
Journal of Hepatology|July 31, 2020
Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testingJohanna Galaski, Christina Weiler-Normann, Miriam Schakat, et al.
Hepatology (Baltimore, Md.)|October 28, 2011
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluationMarc Lütgehetmann, Lida V Mancke, Tassilo Volz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 24, 2000
Activation of the A3 adenosine receptor affects cell cycle progression and cell growthR Brambilla, F Cattabeni, S Ceruti, et al.
Cancer|May 17, 2005
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracyR Houston Thompson, John C Cheville, Christine M Lohse, et al.
United European Gastroenterology Journal|August 1, 2025
Non-Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over-the-Counter MedicationsEwa Wunsch, Linda Krause, Ansgar Wilhelm Lohse, et al.
European Journal of Heart Failure|September 13, 2012
Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-β1-adrenergic receptor antibody neutralization and of immune parametersGötz Münch, Valerie Boivin-Jahns, Hans-Peter Holthoff, et al.
Pageof 345